PNC Financial Services Group Inc. Buys 187 Shares of ICU Medical, Inc. (NASDAQ:ICUI)

PNC Financial Services Group Inc. boosted its stake in ICU Medical, Inc. (NASDAQ:ICUIFree Report) by 7.8% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 2,576 shares of the medical instruments supplier’s stock after purchasing an additional 187 shares during the quarter. PNC Financial Services Group Inc.’s holdings in ICU Medical were worth $257,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds have also added to or reduced their stakes in the company. M&T Bank Corp lifted its holdings in shares of ICU Medical by 5.9% in the fourth quarter. M&T Bank Corp now owns 4,938 shares of the medical instruments supplier’s stock worth $493,000 after buying an additional 277 shares in the last quarter. Gamco Investors INC. ET AL lifted its stake in ICU Medical by 1.1% in the 3rd quarter. Gamco Investors INC. ET AL now owns 24,950 shares of the medical instruments supplier’s stock worth $2,969,000 after purchasing an additional 278 shares in the last quarter. Daiwa Securities Group Inc. boosted its holdings in ICU Medical by 1.2% in the 4th quarter. Daiwa Securities Group Inc. now owns 28,612 shares of the medical instruments supplier’s stock valued at $2,854,000 after purchasing an additional 350 shares during the period. CWM LLC grew its position in shares of ICU Medical by 341.2% during the 4th quarter. CWM LLC now owns 578 shares of the medical instruments supplier’s stock valued at $58,000 after purchasing an additional 447 shares in the last quarter. Finally, Glenmede Trust Co. NA increased its holdings in shares of ICU Medical by 6.2% in the third quarter. Glenmede Trust Co. NA now owns 8,562 shares of the medical instruments supplier’s stock worth $1,019,000 after purchasing an additional 499 shares during the period. Hedge funds and other institutional investors own 96.10% of the company’s stock.

Analyst Ratings Changes

Separately, KeyCorp lifted their price objective on ICU Medical from $134.00 to $136.00 and gave the company an “overweight” rating in a research note on Wednesday, February 28th.

Check Out Our Latest Research Report on ICU Medical

ICU Medical Price Performance

ICUI stock opened at $108.34 on Friday. The company has a debt-to-equity ratio of 0.76, a current ratio of 2.61 and a quick ratio of 1.09. ICU Medical, Inc. has a one year low of $78.28 and a one year high of $196.57. The stock has a market cap of $2.64 billion, a PE ratio of -44.22 and a beta of 0.73. The firm has a 50 day simple moving average of $101.94 and a two-hundred day simple moving average of $98.65.

ICU Medical (NASDAQ:ICUIGet Free Report) last posted its quarterly earnings data on Tuesday, May 7th. The medical instruments supplier reported $0.60 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.54 by $0.06. ICU Medical had a negative net margin of 2.63% and a positive return on equity of 5.38%. The company had revenue of $566.66 million during the quarter, compared to the consensus estimate of $553.15 million. On average, analysts predict that ICU Medical, Inc. will post 3.5 EPS for the current fiscal year.

Insider Transactions at ICU Medical

In other news, VP Daniel Woolson sold 791 shares of the stock in a transaction dated Friday, March 15th. The stock was sold at an average price of $98.27, for a total transaction of $77,731.57. Following the transaction, the vice president now directly owns 13,980 shares in the company, valued at approximately $1,373,814.60. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. In other ICU Medical news, VP Daniel Woolson sold 791 shares of the company’s stock in a transaction that occurred on Friday, March 15th. The stock was sold at an average price of $98.27, for a total value of $77,731.57. Following the completion of the sale, the vice president now owns 13,980 shares of the company’s stock, valued at $1,373,814.60. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director George A. Lopez sold 7,978 shares of the stock in a transaction that occurred on Thursday, March 14th. The shares were sold at an average price of $101.87, for a total transaction of $812,718.86. Following the transaction, the director now owns 877,343 shares in the company, valued at $89,374,931.41. The disclosure for this sale can be found here. In the last three months, insiders sold 25,498 shares of company stock worth $2,633,440. 6.70% of the stock is currently owned by corporate insiders.

ICU Medical Company Profile

(Free Report)

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.

Further Reading

Want to see what other hedge funds are holding ICUI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for ICU Medical, Inc. (NASDAQ:ICUIFree Report).

Institutional Ownership by Quarter for ICU Medical (NASDAQ:ICUI)

Receive News & Ratings for ICU Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical and related companies with MarketBeat.com's FREE daily email newsletter.